keyword
https://read.qxmd.com/read/38643357/successful-treatment-of-lithium-induced-nephrogenic-diabetes-insipidus-with-celecoxib-a-promising-therapeutic-option
#1
JOURNAL ARTICLE
Ryunosuke Hahsikawa, Hiroyuki Yamada, Toshihito Fujii, Shigeru Ohtsuru
BACKGROUND Nephrogenic diabetic insipidus (NDI) poses a challenge in clinical management, particularly when associated with lithium ingestion. Non-selective non-steroidal anti-inflammatory drugs (NSAIDs) have been widely used for the treatment of numerous diseases worldwide, including NDI. However, many studies have reported the diverse adverse effects of long-term use of non-selective NSAIDs. Celecoxib, a selective cyclooxygenase-2 (COX-2) inhibitor, is a better drug to relieve pain and inflammation in terms of long-term safety and efficacy than non-selective NSAIDs...
April 21, 2024: American Journal of Case Reports
https://read.qxmd.com/read/38617725/evaluation-of-clinical-outcomes-of-raised-intraocular-pressure-following-intravitreal-triamcinolone-acetonide-injection
#2
JOURNAL ARTICLE
Pragya Singh, R Krishnaprasad, Guruprasad Ayachit, Shrinivas Joshi
Aim: To assess the incidence, risk factors, and treatment outcomes in intravitreal triamcinolone acetonide injection (IVTA) induced intraocular pressure rise and to compare IOP rise in 1-mg and 2-mg IVTA. Materials and methods: Prospective observational study conducted in all eyes receiving IVTA. Any pre-existing glaucoma and patients who received IVTA or dexamethasone implant in the last 6 months were excluded. Results: 9 between 61-70 years of age developed an IOP spike. The mean and standard deviation of age in years was 61...
2024: Romanian Journal of Ophthalmology
https://read.qxmd.com/read/38611825/channel-expansion-in-the-ligand-binding-domain-of-the-glucocorticoid-receptor-contributes-to-the-activity-of-highly-potent-glucocorticoid-analogues
#3
JOURNAL ARTICLE
Wesley B Seaton, Susan J Burke, Alexander R Fisch, William A Schilletter, Mary Grace A Beck, Gabrielle A Cassagne, Innocence Harvey, Molly S Fontenot, J Jason Collier, Shawn R Campagna
Glucocorticoids (GCs) act through the glucocorticoid receptor (GR) and are commonly used as anti-inflammatory and immunosuppressant medications. Chronic GC use has been linked with unwanted complications such as steroid-induced diabetes mellitus (SIDM), although the mechanisms for these effects are not completely understood. Modification of six GC parent molecules with 2-mercaptobenzothiazole resulted in consistently less promoter activity in transcriptional activation assays using a 3xGRE reporter construct while constantly reducing inflammatory pathway activity...
March 29, 2024: Molecules: a Journal of Synthetic Chemistry and Natural Product Chemistry
https://read.qxmd.com/read/38599841/-pouchitis-showed-complete-response-to-ustekinumab
#4
JOURNAL ARTICLE
Yukako Nemoto, Shinya Tajima, Kota Saito, Arata Satoi, Takashi Matsui, Sei Kimura, Fumihiko Nakamura
Pouchitis is the most common long-term complication following ileal pouch-anal anastomosis (IPAA) in patients with ulcerative colitis. Although several agents, including probiotics, steroids, and immunomodulators, have been used, the treatment of pouchitis remains challenging. Owing to the proven efficacy of biological therapy in inflammatory bowel disease, there is now growing evidence suggesting the potential benefits of biological therapy in refractory pouchitis. Here, we report the case of a 64-year-old woman with pouchitis due to ulcerative colitis who was successfully treated with ustekinumab (UST)...
2024: Nihon Shokakibyo Gakkai Zasshi, the Japanese Journal of Gastro-enterology
https://read.qxmd.com/read/38580798/association-between-moraxella-keratitis-and-advanced-glycation-end-products
#5
JOURNAL ARTICLE
Hidenori Inoue, Koji Toriyama, Naoko Takahira, Shinobu Murakami, Hitoshi Miyamoto, Takashi Suzuki, Atsushi Shiraishi
Diabetes mellitus is recognized as a major predisposing factor for Moraxella keratitis. However, how diabetes mellitus contributes to Moraxella keratitis remains unclear. In this study, we examined Moraxella keratitis; based on the findings, we investigated the impact of advanced glycation end products (AGEs) deposition in the cornea of individuals with diabetic mellitus on the adhesion of Moraxella isolates to the cornea. A retrospective analysis of 27 culture-proven cases of Moraxella keratitis at Ehime University Hospital (March 2006 to February 2022) was performed...
April 5, 2024: Scientific Reports
https://read.qxmd.com/read/38547158/management-of-hypertension-in-heart-transplant-recipients-an-ongoing-conundrum
#6
JOURNAL ARTICLE
Juan Duarte Torres, Selim R Krim
PURPOSE OF REVIEW: Hypertension remains one of the most common clinical problems leading to significant posttransplant complications. This study reviews the pathophysiology of hypertension in the postcardiac transplant phase and provides an update on currently available antihypertensive therapies for heart transplant patients. RECENT FINDINGS: The true prevalence of hypertension in the heart transplant population remains unknown. Effective blood pressure (BP) control is key to prevent left ventricular remodeling, diastolic dysfunction and stroke...
March 28, 2024: Current Opinion in Cardiology
https://read.qxmd.com/read/38544442/pembrolizumab-induced-type-1-diabetes-mellitus-in-a-patient-with-metastatic-melanoma-and-literature-review-on-steroids-as-a-treatment-option
#7
JOURNAL ARTICLE
Adina Greene, Scott Penner, Jacqueline Kunesh, Amal Altaf, William McGrade, Jiaxin Niu
OBJECTIVE: We report a case of a 77-year-old male with metastatic melanoma who developed immune-checkpoint-inhibitor (ICI) induced type 1 diabetes mellitus (T1DM) after seven months of pembrolizumab treatment and required life-long insulin use. This prompted a literature review of best practice guidelines for long-term management of checkpoint-inhibitor induced T1DM including oral steroids as a treatment option similar to other ICI adverse effects. DATA SOURCES AND SUMMARY: A literature search on PubMed was conducted to evaluate the efficacy of steroid treatment ICI-induced T1DM in any cancer type...
March 28, 2024: Journal of Oncology Pharmacy Practice
https://read.qxmd.com/read/38537621/cardiorenal-benefits-of-finerenone-in-different-races-and-kidney-function-in-patients-with-chronic-kidney-disease
#8
REVIEW
Pingjiang Li, Yuying Cui, Xiaoming Xu, Jianjun Dong, Lin Liao
BACKGROUND: Mineralocorticoid receptor plays an important pathophysiological role in cardiorenal diseases by causing inflammation and fibrosis. Mineralocorticoid receptor antagonists (MRAs) are well known in treating cardiovascular disease and diverse nephropathies. However, the first-generation MRA (spironolactone) and the second-generation MRA (eplerenone) remain underutilized because of the risk of inducing severe adverse events. As a selective non-steroidal MRA, finerenone is safer and more effective and improves cardiorenal outcomes in patients with chronic kidney disease (CKD) and type 2 diabetes mellitus (T2DM)...
March 27, 2024: Cardiorenal Medicine
https://read.qxmd.com/read/38531483/fxr-menin-mediated-epigenetic-regulation-of-e2f3-expression-controls-%C3%AE-cell-proliferation-and-is-increased-in-islets-from-diabetic-gk-rats-after-rygb
#9
JOURNAL ARTICLE
Xiangchen Kong, Chenxi Yang, Bingfeng Li, Dan Yan, Yanhui Yang, Cuihua Cao, Bowen Xing, Xiaosong Ma
Farnesoid X receptor (FXR) improves the function of islets, especially in the setting of Roux-en-Y gastric bypass (RYGB). Here we investigated how FXR activation regulates β-cell proliferation and explored the potential link between FXR signaling and the menin pathway in controlling E2F3 expression, a key transcription factor for controlling adult β-cell proliferation. Stimulation with the FXR agonist GW4064 or chenodeoxycholic acid (CDCA) increased E2F3 expression and β-cell proliferation...
March 24, 2024: Biochimica et Biophysica Acta. Molecular Basis of Disease
https://read.qxmd.com/read/38516643/optimal-initial-insulin-dosage-for-managing-steroid-induced-hyperglycemia-in-hospitalized-covid-19-patients-a-retrospective-single-center-study
#10
JOURNAL ARTICLE
Nuttavadee Ketaroonrut, Sasisopin Kiertiburanakul, Chutintorn Sriphrapradang
OBJECTIVES: To determine the optimal initial insulin dosage for controlling hyperglycemia in COVID-19 patients receiving steroids, an area with limited data. METHODS: We retrospectively analyzed 156 COVID-19 patients with steroid-induced hyperglycemia treated with insulin. Patients were categorized by their total daily dose of subcutaneous insulin therapy when starting dexamethasone ⩾6 mg/day or equivalent dose of glucocorticoid: Group A (⩽0...
2024: SAGE Open Medicine
https://read.qxmd.com/read/38510914/prevalence-of-steroid-induced-hyperglycemia-in-king-abdulaziz-specialist-hospital-taif-city-saudi-arabia
#11
JOURNAL ARTICLE
Jehan F Sarriyah, Adel S Alghamdi, Norah M Al-Otaibi, Batool B Abdulrahman, Kholoud M Aljaed
Background Hyperglycemia is a common side effect of high-dose steroid therapy in hospitalized patients. Objectives To assess the prevalence of hyperglycemia among hospitalized patients receiving steroid therapy. Methods A retrospective study was conducted among 245 patients. The inclusion criteria were patients undergoing steroid therapy and admitted to a single tertiary care hospital due to medical complications or exacerbation of the diseases they were suffering from. Data encompassing patient demographics, admission, discharge dates, comorbidities, medication histories, laboratory results (including blood glucose levels), and documented corticosteroid administrations were meticulously gathered from electronic health records (EHRs)...
February 2024: Curēus
https://read.qxmd.com/read/38481492/acute-transient-hyperglycemia-after-steroid-induction-at-transplant-strongly-predicts-new-onset-diabetes-and-recurrence-of-diabetic-nephropathy
#12
JOURNAL ARTICLE
Carlotta Federica Zizzi, Caterina Dolla, Fabrizio Fop, Alberto Mella, Michela Sandrone, Ezio Ghigo, Silvana Bertaina, Fabio Broglio, Ester Gallo, Antonella Barreca, Guglielmo Beccuti, Franco Veglio, Alberto Milan, Antonio Lavacca, Roberta Giraudi, Luigi Biancone
No abstract text is available yet for this article.
March 2024: KI Reports
https://read.qxmd.com/read/38469413/a%C3%A2-case-report-and-systematic-literature-review-insulin-induced-type-iii-hypersensitivity-reaction
#13
Rebecca R Meredith, Pooja Patel, Polly Huang, Chinelo Pamela Onyenekwu, Herleen Rai, Jody Tversky, Santiago Alvarez-Arango
Insulin-induced type III hypersensitivity reactions (HSRs) are exceedingly rare and pose complex diagnostic and management challenges. We describe a case of a 43-year-old woman with type 1 diabetes mellitus (DM), severe insulin resistance, and subcutaneous nodules at injection sites, accompanied by elevated anti-insulin IgG autoantibodies. Treatment involved therapeutic plasma exchange (TPE) and intravenous immunoglobulin (IVIg) as bridge therapy, followed by long-term immunosuppression, which reduced autoantibody levels and improved insulin tolerance...
2024: Front Allergy
https://read.qxmd.com/read/38469333/nsaid-nonsteroidal-anti-inflammatory-drugs-induced-stevens-johnson-syndrome-in-a-50-year-old-woman-a-case-study
#14
Navid Faraji, Rasoul Goli, Pariya Mohsennezhad, Yousef Mohammadpour, Naser Parizad, Elaheh Salamat, Raheleh Pourbahram, Samaneh Bazbandi
Stevens-Johnson Syndrome (SJS) is a severe and rare adverse drug reaction associated with significant morbidity and mortality. Although SJS is commonly triggered by multiple drugs, non-steroidal anti-inflammatory drugs (NSAIDs), including diclofenac, have been frequently implicated. A middle-aged woman, who is 50 years old, has a prior medical record of high blood pressure, type 2 diabetes, and has recently suffered from a pulmonary embolism. She was later admitted to the intensive care unit (ICU), where she was ultimately diagnosed with Steven Johnson syndrome...
June 2024: Toxicology Reports
https://read.qxmd.com/read/38451877/the-glucocorticoid-receptor-in-skeletal-health-and-disease-insights-from-targeted-knockout-mice
#15
REVIEW
Eugenie Macfarlane, Hong Zhou, Markus J Seibel
Glucocorticoids are steroid hormones, secreted by the adrenals to regulate a range of metabolic, immunologic, and homeostatic functions. Due to their potent anti-inflammatory effects, synthetic glucocorticoids are widely used to treat inflammatory disorders. However, their use especially at high doses and over the long-term is associated with several unwanted side effects that compromises their intended use (e.g., glucocorticoid-induced osteoporosis and/or diabetes, myopathy, and skin atrophy). Both endogenous and synthetic glucocorticoids exert their effects through the glucocorticoid receptor, a transcription factor present in nearly all nucleated cells...
March 1, 2024: Journal of Endocrinology
https://read.qxmd.com/read/38406132/awareness-of-the-risk-of-chronic-use-of-steroid-causing-cataract-in-al-ahsa-city-saudi-arabia
#16
JOURNAL ARTICLE
Abdulaziz I AlSomali, Hajar M AlHajri, Rawabi Aljumaiah, Muntaha N Alnasser, Zainab Alabdullah
Introduction The lens, essential for vision, can be impaired by cataracts, leading to partial or complete reversible vision loss. Common risk factors include aging, diabetes, and steroid use, with significant financial implications. Limited awareness in Saudi Arabia necessitates further research to reduce cataract prevalence and increase knowledge about steroid-induced cataracts. Methodology This was a cross-sectional study in Al Ahsa City, Saudi Arabia that aims to assess awareness of cataracts induced by long-term steroid use...
January 2024: Curēus
https://read.qxmd.com/read/38347623/high-fat-and-high-sucrose-diet-impairs-female-reproduction-by-altering-ovarian-transcriptomic-and-metabolic-signatures
#17
JOURNAL ARTICLE
Congcong Liu, Yunde Dou, Mengge Zhang, Shan Han, Shourui Hu, Yuxuan Li, Zhiheng Yu, Yue Liu, Xiaofan Liang, Zi-Jiang Chen, Han Zhao, Yuqing Zhang
BACKGROUND: Excessive energy intake in modern society has led to an epidemic surge in metabolic diseases, such as obesity and type 2 diabetes, posing profound threats to women's reproductive health. However, the precise impact and underlying pathogenesis of energy excess on female reproduction remain unclear. METHODS: We established an obese and hyperglycemic female mouse model induced by a high-fat and high-sucrose (HFHS) diet, then reproductive phenotypes of these mice were evaluated by examing sexual hormones, estrous cycles, and ovarian morphologies...
February 12, 2024: Journal of Translational Medicine
https://read.qxmd.com/read/38340904/1-25-oh-2-d-3-improves-diabetic-wound-healing-by-modulating-inflammation-and-promoting-angiogenesis
#18
JOURNAL ARTICLE
Yiming Ma, Yiting Gong, Ying Wu, Qiaofan Zhao, Ruyu Fu, Xiaoming Zhang, Ye Li, Xueyuan Zhi
Vitamin D was found to regulate inflammatory response and angiogenesis, which were often impaired in diabetic wound healing. This study aimed to investigate the effects of 1,25-dihydroxyvitamin D3 [1,25(OH)2 D3 ] on diabetic wound healing both in vivo and in vitro. Diabetes was induced by high-fat diet combined with streptozotocin. After four weeks of establishing diabetic mouse model, full-thickness excisional wounds were created on their dorsal skin. Then 1,25(OH)2 D3 was administered via intraperitoneal injection for 14 consecutive days...
February 8, 2024: Journal of Steroid Biochemistry and Molecular Biology
https://read.qxmd.com/read/38313305/celecoxib-ameliorates-diabetic-sarcopenia-by-inhibiting-inflammation-stress-response-mitochondrial-dysfunction-and-subsequent-activation-of-the-protein-degradation-systems
#19
JOURNAL ARTICLE
Chunyan Deng, Chunfeng Lu, Kexin Wang, Mengyuan Chang, Yuntian Shen, Xiaoming Yang, Hualin Sun, Xinlei Yao, Chunjian Qiu, Feng Xu
Aim: Diabetic sarcopenia leads to disability and seriously affects the quality of life. Currently, there are no effective therapeutic strategies for diabetic sarcopenia. Our previous studies have shown that inflammation plays a critical role in skeletal muscle atrophy. Interestingly, the connection between chronic inflammation and diabetic complications has been revealed. However, the effects of non-steroidal anti-inflammatory drug celecoxib on diabetic sarcopenia remains unclear. Materials and Methods: The streptozotocin (streptozotocin)-induced diabetic sarcopenia model was established...
2024: Frontiers in Pharmacology
https://read.qxmd.com/read/38307092/ferroptosis-a-frontier-in-osteoporosis
#20
JOURNAL ARTICLE
Shubhrat Maheshwari, Aditya Singh, Amita Verma
Reduced bone mass and degeneration of the microarchitecture of bone tissue are the hallmarks of osteoporosis, a bone metabolic disease that increases skeletal fragility and fracture susceptibility. Osteoporosis is primarily caused by unbalanced bone remodeling, in which bone synthesis is outpaced by bone resorption caused by osteoclasts. Along with the bone-building vitamins calcium and vitamin D, typical medications for treating osteoporosis include bisphosphonates and calcitonin. The present therapies effectively stop osteoclast activation that is too high, however they come with varying degrees of negative effects...
February 2, 2024: Hormone and Metabolic Research
keyword
keyword
77533
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.